Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.62 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.41 |
| ▸ | USP2 | O75604 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.34 |
| ▸ | EPAS1 | Q99814 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL515417 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TSHRTRPA1USP2MAPT | |
| SCHEMBL3119157 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TSHRTRPA1USP2MAPT | |
| SCHEMBL347298 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TSHRTRPA1USP2MAPT | |
| SCHEMBL28285571 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TSHRTRPA1USP2MAPT | |
| SCHEMBL515877 | 1.00 | — | — | |
| SCHEMBL1727419 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TSHRTRPA1USP2MAPT | |
| SCHEMBL2390939 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TSHRTRPA1USP2MAPT | |
| SCHEMBL30319228 | 1.00 | ALDH1A1 (0.62) | ALDH1A1TSHRTRPA1USP2MAPT | |
| SCHEMBL151637 | 0.97 | — | — | |
| SCHEMBL150327 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109557764-B | Chemically amplified positive photosensitive resin composition, resist pattern, method for forming the same, and electronic device | 奇美实业股份有限公司 | 2023-09-12 | — | — | CN | disclosed |
| CN-109557764-A | Chemically amplified positive photosensitive resin composition, resist pattern and method for forming the same, and electronic device | 奇美实业股份有限公司 | 2019-04-02 | — | — | CN | disclosed |
| US-9221745-B2 | Process for preparing amino acids or esters comprising a metathesis step | ARKEMA FRANCE (FR) | 2015-12-29 | — | — | US | disclosed |
| CN-103917517-A | Process for preparing amino acids or esters comprising a metathesis step | ARKEMA FRANCE | 2014-07-09 | — | — | CN | disclosed |
| US-20140163196-A1 | PROCESS FOR PREPARING AMINO ACIDS OR ESTERS COMPRISING A METATHESIS STEP | ARKEMA FRANCE (FR) | 2014-06-12 | — | — | US | disclosed |
| EP-2739604-A1 | PROCESS FOR PREPARING AMINO ACIDS OR ESTERS COMPRISING A METATHESIS STEP | Arkema France (FR) | 2014-06-11 | — | — | EP | disclosed |
| WO-2013017786-A1 | PROCESS FOR PREPARING AMINO ACIDS OR ESTERS COMPRISING A METATHESIS STEP | ARKEMA FRANCE (FR) | 2013-02-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140163196-A1 | PROCESS FOR PREPARING AMINO ACIDS OR ESTERS COMPRISING A METATHESIS STEP | FASN, METTL14, ALAD | ALDH1A1 1324/4885TSHR 3697/4885TRPA1 3036/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.